Compare ADMA Biologics Inc (ADMA) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while iShares 10 20 Year Treasury Bond ETF trades at $96.55. The key difference: ADMA Biologics Inc is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ADMA | TLH | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Fixed Income |
52-Week High | $20.38 | $105.36 |
52-Week Low | $7.60 | $96.39 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
